Benefits to Attending...
Gain a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology. Our congress brings together immuno-oncology experts across six tracks to provide a comprehensive look at the key trends in this industry, from therapeutic strategies and modelling through to the latest clinical data
Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, oncolytic viruses, bispecific drugs and cancer vaccines
Advance your understanding of topical technological innovation, from single cell analysis approaches to biomarker technologies like liquid biopsies, immunohistochemistry and Cytof
Examine the latest challenges and technological innovations in preclinical development with discussions on animal modelling techniques and screening strategies along with key, preclinical considerations to drive successful entry into the clinical phase
Unparalleled networking opportunities. Take advantage of ample in-person and online networking opportunities to enable high-level scientific and business discussions
Gain the latest insights into the tumour microenvironment. See how spatial biology, imaging and pathology are elucidating the key biology of solid tumours, and highlighting potential therapeutic approaches
Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features
Gain a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology. Our congress brings together immuno-oncology experts across six tracks to provide a comprehensive look at the key trends in this industry, from therapeutic strategies and modelling through to the latest clinical data
Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, oncolytic viruses, bispecific drugs and cancer vaccines
Advance your understanding of topical technological innovation, from single cell analysis approaches to biomarker technologies like liquid biopsies, immunohistochemistry and Cytof
Examine the latest challenges and technological innovations in preclinical development with discussions on animal modelling techniques and screening strategies along with key, preclinical considerations to drive successful entry into the clinical phase
Unparalleled networking opportunities. Take advantage of ample in-person and online networking opportunities to enable high-level scientific and business discussions
Gain the latest insights into the tumour microenvironment. See how spatial biology, imaging and pathology are elucidating the key biology of solid tumours, and highlighting potential therapeutic approaches
Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features
